(Q34570769)

3 August 2017

title

High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma (English)

1 reference

3 August 2017

1 reference

Basak Oyan

1

1 reference

3 August 2017

Yener Koc

2

1 reference

3 August 2017

Evren Ozdemir

3

1 reference

3 August 2017

Ayse Kars

4

1 reference

3 August 2017

Alev Turker

5

1 reference

3 August 2017

Gulten Tekuzman

6

1 reference

3 August 2017

Emin Kansu

7

1 reference

3 August 2017

publication date

1 August 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

47

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

1545-1552

1 reference

Treatment of non-Hodgkin's lymphoma

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600570958

10.1080/10428190600570958

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference